NU
NUTX.US Nutex Health Inc
- Market cap
- USD 1.19B
- P/E
- 7.5x
- P/B
- 2.74x
- ROE
- 46.8%
- Dividend yield
- 6.23%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is NUTX.US undervalued?
Graham numberNUTX.US trades 4.4% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nutex Health Inc fundamental analysis
No fundamental analysis for Nutex Health Inc yet.
Nutex Health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nutex Health Inc
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan…
Full company profileNutex Health Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Nutex Health Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 53.6K | 91.4K | 97.1M | 274M | 332M | 219M | 248M | 480M | 875M | 860M |
| Gross Profit | -473.00 | 53.6K | 29.1K | 56.9M | 158M | 179M | 15.4M | 34.8M | 196M | 444M | 446M |
| Operating Income | -449K | -5.69M | -1.83M | 34.7M | 153M | 170M | -407M | -31.8M | 131M | 276M | 373M |
| EBITDA | -448K | -5.69M | -1.83M | 38.1M | 158M | 183M | -394M | -14.6M | 149M | 288M | 396M |
| Net Income | -7.43M | 582K | -2.81M | 20.9M | 106M | 133M | -425M | -45.8M | 52.2M | 70.8M | 204M |
| EPS | -3.60 | 0.14 | -0.39 | 5.05 | 25 | 34 | -100 | -10 | 10 | 10 | 29 |
| Balance Sheet | |||||||||||
| Total Assets | 511K | 3.33M | 449K | 179M | 309M | 395M | 432M | 398M | 655M | 919M | 1.03B |
| Total Liabilities | 6.38M | 960K | 1.95M | 128M | 161M | 203M | 311M | 319M | 453M | 495M | 491M |
| Shareholders' Equity | -5.87M | 2.37M | -1.50M | 28.3M | 85.8M | 115M | 95.9M | 61.5M | 146M | 329M | 436M |
| Cash & Short-term Investments | 10.5K | 9.45K | 119K | 8.00M | 25.5M | 36.1M | 34.3M | 22.0M | 43.6M | 186M | 250M |
| Total Debt | 50.0K | 386K | 1.38M | 120M | 150M | 179M | 267M | 276M | 340M | 351M | 365M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -274K | -715K | -480K | 12.1M | 81.3M | 173M | 50.6M | 1.26M | 23.2M | 248M | 251M |
| Capital Expenditure | 3.00 | 3.00 | 0.00 | 32.3M | 61.2M | 36.9M | 14.6M | 9.50M | 2.30M | 2.53M | 6.59M |
| Free Cash Flow | -274K | -715K | -480K | -20.2M | 20.1M | 137M | 36.0M | -8.24M | 20.8M | 246M | 244M |
| Ratios | |||||||||||
| ROE | - | 24.6% | - | 73.9% | 123.5% | 115.6% | -443.1% | -74.5% | 35.7% | 21.5% | 46.8% |
| ROA | -1,454.9% | 17.5% | -626.2% | 11.7% | 34.3% | 33.6% | -98.4% | -11.5% | 8.0% | 7.7% | 19.7% |
| Net Profit Margin | - | 1,085.0% | -3,080.0% | 21.6% | 38.7% | 40.0% | -193.7% | -18.5% | 10.9% | 8.1% | 23.7% |
| Debt to Equity | - | 0.16x | - | 4.24x | 1.75x | 1.56x | 2.79x | 4.49x | 2.33x | 1.07x | 0.84x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Nutex Health Inc dividends
- Dividend yield
- 6.23%
- Forward dividend
- -
- Payout ratio
- 104.9%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 74.3M | 11 | 104.9% |
| 2024 | USD 6.44M | 1.26 | 12.3% |
| 2023 | USD 5.21M | 1.18 | - |
| 2022 | USD 51.2M | 12 | - |
| 2021 | USD 144M | 37 | 108.9% |
| 2020 | USD 59.1M | 14 | 55.7% |
| 2019 | USD 18.9M | 4.57 | 90.3% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10 on Jul 3, 2024.
Who owns Nutex Health Inc
- Insiders 30.33%
- Institutions 48.28%
- Public & others 21.39%
- Shares outstanding 6.86M
- Free float 4.09M
Top funds holding NUTX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Avantis US Small Cap Value ETF | 290K | 4.23% | +0.62% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 141K | 2.06% | -7.70% | Sep 2026 |
| iShares Russell 2000 ETF | 127K | 1.85% | 0.00% | Oct 2026 |
| Bexil Investment Trust | 62.0K | 0.90% | 0.00% | Sep 2026 |
| Fidelity Small Cap Index | 55.0K | 0.80% | +0.27% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 47.0K | 0.68% | -0.38% | Oct 2026 |
| Pacer US Small Cap Cash Cows 100 ETF | 42.4K | 0.62% | +0.23% | Oct 2026 |
| First Trust Small Cap Gr AlphaDEX® ETF | 40.6K | 0.59% | +0.43% | Oct 2026 |
| VictoryShares Small Cap Fr CA Flw ETF | 36.7K | 0.54% | +0.31% | Oct 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 33.8K | 0.49% | 0.00% | Oct 2026 |
| Vanguard Russell 2000 ETF | 29.2K | 0.43% | +1.14% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 24.4K | 0.36% | +0.13% | Oct 2026 |
| Fidelity Extended Market Index | 21.2K | 0.31% | -13.52% | Sep 2026 |
| Hussman Strategic Market Cycle Fund | 20.0K | 0.29% | 0.00% | Mar 2026 |
| First Trust Small Cap Core AlphaDEX® ETF | 19.9K | 0.29% | 0.00% | Oct 2026 |
| Stt Strt® SPDR® S&P®HlthCrSvcsETF | 19.4K | 0.28% | 0.00% | Oct 2026 |
| Avantis® U.S. Small Cap Value Instl | 18.5K | 0.27% | 0.00% | Sep 2026 |
| iShares Micro-Cap ETF | 15.2K | 0.22% | 0.00% | Oct 2026 |
| Bridgeway Omni Small-Cap Value N | 15.0K | 0.22% | 0.00% | Jun 2026 |
| Schwab Small Cap Index | 12.3K | 0.18% | 0.00% | Sep 2026 |
Top institutions holding NUTX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Pertento Partners LLP | 451K | 6.58% | +20.68% | Jun 2026 |
| BlackRock Inc | 407K | 5.94% | +7.38% | Jun 2026 |
| American Century Companies Inc | 324K | 4.72% | +36.40% | Sep 2026 |
| Vanguard Capital Management, LLC | 216K | 3.15% | -1.47% | Jun 2026 |
| Geode Capital Management, LLC | 132K | 1.93% | +8.14% | Jun 2026 |
| State Street Corp | 131K | 1.91% | +6.22% | Jun 2026 |
| D. E. Shaw & Co LP | 97.5K | 1.42% | 0.00% | Jun 2026 |
| UBS Group AG | 77.9K | 1.14% | +11.99% | Jun 2026 |
| Winmill & Co Inc | 65.4K | 0.95% | 0.00% | Sep 2026 |
| The Colony Group LLC | 60.9K | 0.89% | 0.00% | Jun 2026 |
| Millennium Management LLC | 52.1K | 0.76% | -41.83% | Jun 2026 |
| The Goldman Sachs Group Inc | 51.2K | 0.75% | +51.63% | Jun 2026 |
| Bridgeway Capital Management, LLC | 46.9K | 0.68% | +212.41% | Jun 2026 |
| Empowered Funds, LLC | 45.2K | 0.66% | +39.22% | Jun 2026 |
| Pacer Advisors, INC. | 44.6K | 0.65% | +55.58% | Jun 2026 |
| Northern Trust Corp | 44.1K | 0.64% | +6.76% | Jun 2026 |
| Topline Capital Management LLC | 41.8K | 0.61% | -76.51% | Jun 2026 |
| ONE + ONE WEALTH MANAGEMENT, LLC | 40.4K | 0.59% | 0.00% | Jun 2026 |
| LSV Asset Management | 36.1K | 0.53% | 0.00% | Sep 2026 |
| Vanguard Fiduciary Trust Co | 36.0K | 0.52% | +0.39% | Jun 2026 |
Nutex Health Inc company profile
- Company name
- Nutex Health Inc
- Ticker
- NUTX.US
- Exchange
- USA Stocks
- Listed since
- Apr 4, 2022
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,093
- Fiscal year end
- December
- Address
- 1776 Yorktown Street, Houston, TX, United States, 77056
- Phone
- 713 660 0557
- Website
- nutexhealth.com
About Nutex Health Inc
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
Nutex Health Inc management
10- Dr. Thomas T. Vo M.B.A., M.D.Chairman of the Board & CEO · born 1973
- Dr. Warren Hosseinion M.D.President & Director · born 1972
- Mr. Jon C. Bates CPA, M.B.A.Chief Financial Officer · born 1971
- Mr. Wesley Bamburg FACHEChief Operating Officer
- Dr. Michael Chang M.D.Chief Medical Officer · born 1972
- Ms. Jennifer RodriguezInvestor & Public Relations Manager
- Ms. LaTanya BrackensDirector of Compliance
- Ms. Vivian Sanders M.B.A.Director of Marketing
- Ms. Sarah WallaceDirector of Human Resources
- Ms. Elisa Michael Luqman Esq., J.D., M.B.A.Chief Legal Officer & Board Secretary of SEC · born 1964